Compare TEVA & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | EL |
|---|---|---|
| Founded | 1901 | 1946 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5B | 34.2B |
| IPO Year | 1996 | 2007 |
| Metric | TEVA | EL |
|---|---|---|
| Price | $40.88 | $101.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 30 |
| Target Price | $47.17 | ★ $107.34 |
| AVG Volume (30 Days) | ★ 5.3M | 2.7M |
| Earning Date | 11-03-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 1.40% |
| EPS Growth | ★ 183.45 | 115.87 |
| EPS | N/A | ★ 0.50 |
| Revenue | N/A | ★ $15,049,000,000.00 |
| Revenue This Year | N/A | $4.51 |
| Revenue Next Year | $3.39 | $4.28 |
| P/E Ratio | ★ N/A | $199.46 |
| Revenue Growth | N/A | ★ 5.05 |
| 52 Week Low | $18.83 | $66.22 |
| 52 Week High | $42.02 | $121.64 |
| Indicator | TEVA | EL |
|---|---|---|
| Relative Strength Index (RSI) | 62.59 | 62.59 |
| Support Level | $30.41 | $89.74 |
| Resistance Level | N/A | $104.74 |
| Average True Range (ATR) | 1.06 | 2.84 |
| MACD | 0.07 | 0.77 |
| Stochastic Oscillator | 69.76 | 99.57 |
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top-selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.